trastuzumab emtansine

Ligand id: 6928

Name: trastuzumab emtansine

References
1. Hudziak RM, Shepard HM, Ullrich A. (1989)
Method of treating tumor cells by inhibiting growth factor receptor function.
Patent number: WO1989006692. Assignee: Genentech Inc. Priority date: 12/01/1988. Publication date: 27/07/1989.
2. Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, Bl├Ąttler WA, Lambert JM, Chari RV, Lutz RJ et al.. (2008)
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.
Cancer Res.68 (22): 9280-90. [PMID:19010901]